|
|
This activity is provided by the Discovery Institute of Medical Education.
This activity is supported by an educational grant from the Bristol-Myers Squibb/Sanofi Pharmaceutical Partnership.
|
 |
The Discovery Institute of Medical Education designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Please note that the course is accredited only for physicians (MD, DO, or equivalent). All other participants receive a certificate of completion. In accordance with the Discovery Institute of Medical Education policies regarding financial and off-label disclosures, participants are advised that this CME activity may contain references to off-label or unapproved uses of drugs or devices. Participants should note that the use of these agents outside current approved labeling is considered experimental and are advised to consult prescribing information for these products. © 2006-2007 Discovery Institute of Medical Education
Activity Purpose The Atherosclerosis Risk in Communities (ARIC) study has collected many important new findings relative to PAD, including (but not limited to) the rate of development of PAD in individuals with diabetes, the effect of depression and psychosocial variables on development of PAD, and the rate of development of PAD in individuals with chronic kidney disease. Despite these key findings, the clinical community is relatively unaware of the ARIC data, and the epidemiological community is unaware of how to create accessible slides for CME or clinical audience presentation. This CME activity is designed to address these problems. Statement of Need Patients with PAD have a 15-fold greater risk of death due to cardiovascular causes than patients without evidence of PAD. In fact, PAD may serve as a marker for myocardial infarction and ischemic stroke. PAD is caused by atherosclerotic buildup in peripheral arteries, limiting blood flow to the lower extremities. The clinical symptom is intermittent claudication characterized by pain, aches, or fatigue in leg muscles upon ambulation. This pain does not occur in resting muscles. Although prevalence estimates vary depending on the definition used, PAD is underdiagnosed, and a significant number of patients with asymptomatic PAD are at risk for complications. Furthermore, only a small percentage of patients with PAD receive any treatment. Risk factor reduction (ie, smoking cessation, exercise, diet) and antiplatelet therapies, such as aspirin and/or clopidogrel, are the key components of treatment. Learning Objectives Upon completion of this activity, participants should be able to
Accreditation Statement The Discovery Institute of Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Designation Statement The Discovery Institute of Medical Education designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Faculty Disclosures The Discovery Institute of Medical Education requires that those involved with content development and/or presentation disclose to participants any significant financial interest or other relationship (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. Aaron R. Folsom, MD, MPH Alan T. Hirsch, MD Keattiyoat Wattanakit, MD, MPH Instructions to Participants Course participants must view the slide presentations and complete both a test and a course evaluation to receive continuing medical education credit. No fees are charged to participate in the program or to receive the certificate. Full instructions are available on the user instructions page. Disclaimer The opinions expressed herein are those of the faculty and do not necessarily represent the views of the sponsors, commercial supporters, or publisher. Please review complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients. Medicine is a constantly changing science, and clearly established therapies are not always available for every condition. New research findings necessitate continual changes in drug and treatment therapies. Reasonable efforts have been made to provide up-to-date, accurate information that is within generally accepted medical standards at the time of publication. However, as medical science is ever evolving, and human error is always possible, the provider, commercial supporters, and publisher (or any other involved party) do not guarantee total accuracy or comprehensiveness of the information in this article, and they are not responsible for omissions or errors or the results of using information provided in this course. Participants should confirm the accuracy of the information in this activity from other sources. In particular, all drug doses, indications, and contraindications should be confirmed in package inserts.Click here to view minimum system requirements.
|
